A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants

Background Two recent studies identified a mutation (p.Asp620Asn) in the vacuolar protein sorting 35 gene as a cause for an autosomal dominant form of Parkinson disease . Although additional missense variants were described, their pathogenic role yet remains inconclusive. Methods and results We performed the largest multi-center study to ascertain the frequency and pathogenicity of the reported vacuolar protein sorting 35 gene variants in more than 15,000 individuals worldwide. p.Asp620Asn was detected in 5 familial and 2 sporadic PD cases and not in healthy controls, p.Leu774Met in 6 cases and 1 control, p.Gly51Ser in 3 cases and 2 controls. Overall analyses did not reveal any significant increased risk for p.Leu774Met and p.Gly51Ser in our cohort. Conclusions Our study apart from identifying the p.Asp620Asn variant in familial cases also identified it in idiopathic Parkinson disease cases, and thus provides genetic evidence for a role of p.Asp620Asn in Parkinson disease in different populations worldwide.

• Publication year

  2012

• Venue

  Journal of Medical Genetics

• Publication date

  2012-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jmedgenet-2012-101155PMID 23125461PMCID 3488700
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• O 1-7-4-2 Abnormal autophagy / lysosome function may play some role in Parkinson ’ s disease

  2018cited by this paper
• Identification of VPS35 mutations replicated in French families with Parkinson disease

  2012cited by this paper
• VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population.

  2012cited by this paper
• Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population.

  2012cited by this paper
• Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2

  2012cited by this paper
• Treatment of fragile X–associated tremor/ataxia syndrome with unilateral deep brain stimulation

  2012cited by this paper
• Screening for VPS35 mutations in Parkinson's disease

  2012cited by this paper
• Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population.

  2011cited by this paper
• Exome sequencing: a transformative technology.

  2011cited by this paper
• Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.

  2011cited by this paper
• A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.

  2011influential reference
• VPS35 mutations in Parkinson disease.

  2011cited by this paper
• Balance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease

  2010cited by this paper
• PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1

  2010influential reference
• Correction

  2009cited by this paper
• Validating, augmenting and refining genome-wide association signals

  2009cited by this paper
• Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease

  2009cited by this paper
• Uncertainty in heterogeneity estimates in meta-analyses

  2007cited by this paper
• The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

  2007influential reference
• Model‐guided microarray implicates the retromer complex in Alzheimer's disease

  2005cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Apolipoprotein E genotype in familial Parkinson's disease. The French Parkinson's Disease Genetics Study Group.

  1997cited by this paper

• The VPS35 protein and the role of its impairments in mitochondrial dysfunction in Parkinson’s disease

  2026cites this paper
• Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease

  2025cites this paper
• Exploring GBA1 gene in Parkinson's disease: Prevalence and variant spectrum from Asia minor

  2025cites this paper
• Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background

  2025influential citation
• Exploring the triad: VPS35, neurogenesis, and neurodegenerative diseases

  2024cites this paper
• The crucial role of VPS35 and SHH in Parkinson's disease: Understanding the mechanisms behind the neurodegenerative disorder.

  2024cites this paper
• Pain in monogenic Parkinson’s disease: a comprehensive review

  2023cites this paper
• Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”

  2023cites this paper
• Identification of high-performing antibodies for Vacuolar protein sorting-associated protein 35 (hVPS35) for use in Western Blot, immunoprecipitation and immunofluorescence

  2023cites this paper
• Validation of the ACMG/AMP guidelines-based seven-category variant classification system

  2023cites this paper
• Genetics of cognitive dysfunction in Parkinson's disease.

  2022cites this paper
• The LRRK2 signaling network converges on a centriolar phospho-Rab10/RILPL1 complex to cause deficits in centrosome cohesion and cell polarization

  2022cites this paper
• Defective Mitochondrial Dynamics Underlie Manganese-Induced Neurotoxicity

  2021cites this paper
• Parkinson’s Disease Causative Mutation in Vps35 Disturbs Tetherin Trafficking to Cell Surfaces and Facilitates Virus Spread

  2021cites this paper
• LRRK2 causes centrosomal deficits via phosphorylated Rab10 and RILPL1 at centriolar subdistal appendages

  2021cites this paper
• Neurodegenerative disorders and the current state, pathophysiology and management of Parkinson's disease.

  2021cites this paper
• Modelling the functional genomics of Parkinson’s disease in Caenorhabditis elegans: LRRK2 and beyond

  2021cites this paper
• Genotype-Phenotype Correlations in Monogenic Parkinson Disease: A Review on Clinical and Molecular Findings

  2021cites this paper
• Etiology and pathogenesis of Parkinson disease

  2021cites this paper
• Structural and Functional Impact of Damaging Nonsynonymous Single Nucleotide Polymorphisms (nsSNPs) on Human VPS35 Protein Using Computational Approaches

  2021cites this paper
• Parkinson's disease

  2021cites this paper
• Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease

  2021cites this paper
• Clinical manifestations of Parkinson's disease harboring VPS35 retromer complex component p.D620N with long-term follow-up.

  2021cites this paper
• Community‐based genetic study of Parkinson's disease in Estonia

  2020cites this paper
• Genetic and Phenotypic Basis of Autosomal Dominant Parkinson's Disease in a Large Multi-Center Cohort

  2020cites this paper
• Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells

  2020cites this paper
• The Role of VPS35 in the Pathobiology of Parkinson’s Disease

  2020cites this paper
• Endosomal sorting pathways in the pathogenesis of Parkinson's disease.

  2020cites this paper
• Pathways of protein synthesis and degradation in PD pathogenesis.

  2020cites this paper
• Etiology of Parkinson’s Disease – New Advances and New Challenges

  2020cites this paper
• Genetics of Parkinson's disease.

  2020cites this paper
• Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson’s Disease

  2020cites this paper
• Are genetic and idiopathic forms of Parkinson's disease the same disease?

  2020cites this paper
• Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells

  2020cites this paper
• Formation of retromer transport carriers is disrupted by the Parkinson disease‐linked Vps35 D620N variant

  2020cites this paper
• (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model

  2020cites this paper
• Current clinical approaches in neurodegenerative diseases

  2020cites this paper
• Biallelic inheritance of hypomorphic PKD1 variants is highly prevalent in very early onset polycystic kidney disease

  2020cites this paper
• Unveiling the cryo-EM structure of retromer.

  2020cites this paper
• Profiling Non-motor Symptoms in Monogenic Parkinson’s Disease

  2020influential citation
• Endocytic iron trafficking and mitochondria in Parkinson's disease.

  2019cites this paper
• Evolving and Expanding the Roles of Mitophagy as a Homeostatic and Pathogenic Process.

  2019cites this paper
• SocialWork 11-17-2017 Mitochondria : A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson ’ s Disease

  2019cites this paper
• 'Atypical' Parkinson's disease - genetic.

  2019cites this paper
• Investigating early functional alteration in a human iPSC-based model of Parkinson’s Disease

  2019cites this paper
• VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease

  2019cites this paper
• Contributions of VPS35 Mutations to Parkinson's Disease.

  2019cites this paper
• The functional roles of retromer in Parkinson's disease

  2018cites this paper
• Title ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson ' s Disease

  2018cites this paper
• Genotype‐phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review

  2018cites this paper
• Genetics of Parkinson disease.

  2018cites this paper
• Pipeline to gene discovery - Analysing familial Parkinsonism in the Queensland Parkinson's Project.

  2018cites this paper
• The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human

  2018cites this paper
• Gene Linkage and Systems Biology.

  2017cites this paper
• Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson’s Disease

  2017cites this paper
• Role of the VPS35 D620N mutation in Parkinson's disease.

  2017cites this paper
• Advances in the Clinical Differential Diagnosis of Parkinson's Disease.

  2017cites this paper
• Genetics of Parkinson's Disease: Genotype-Phenotype Correlations.

  2017cites this paper
• Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases

  2017cites this paper
• Nonmotor Signs in Genetic Forms of Parkinson's Disease.

  2017cites this paper
• Genetic variation associated with the occurrence and progression of neurological disorders.

  2017cites this paper
• An updated review of Parkinson's disease genetics and clinicopathological correlations

  2017cites this paper
• Retromer Dysfunction and Neurodegenerative Disease

  2017cites this paper
• VPS35, the Retromer Complex and Parkinson’s Disease

  2017cites this paper
• Control of mitochondrial homeostasis by endocytic regulatory proteins

  2017cites this paper
• ATP Maintenance via Two Types of ATP Regulators Mitigates Pathological Phenotypes in Mouse Models of Parkinson's Disease

  2017influential citation
• Genetics of Movement Disorders

  2017cites this paper
• An investigation into the genetic architecture of multiple system atrophy and familial Parkinson's disease

  2017cites this paper
• VPS35-Linked Parkinson’s Disease Resembles the Idiopathic Disease: A Review of Clinical Trials

  2017cites this paper
• Etude des mécanismes cellulaires et moléculaires impliqués dans les effets neuroprotecteurs du gliopeptide OctaDecaNeuropeptide (ODN) dans un model murin de la Maladie de Parkinson

  2017cites this paper
• Mitochondrial Dynamics in Neurodegenerative Diseases

  2017cites this paper
• Modulation der Basalganglienaktivität durch Tiefe Hirnstimulation

  2016cites this paper
• Identification of genetic modifiers in LRRK2 parkinsonism

  2016cites this paper
• Endolysosomal Dysfunction in Parkinson Disease: The Role of Disease Mutations in ATP13A2 and LRRK2.

  2016cites this paper
• Studying the Prevalence and Genetic Contributions to Parkinsonism in Pakistan

  2016influential citation
• Dissecting the Genetic Basis of Parkinson Disease, Dystonia and Chorea

  2016cites this paper
• Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico.

  2016cites this paper
• Vacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of Disease

  2016influential citation
• Autosomal dominant Parkinson's disease caused by SNCA duplications.

  2016cites this paper
• Genetics of Parkinson's disease.

  2016cites this paper
• Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.

  2016cites this paper
• An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.

  2016cites this paper
• The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review

  2015cites this paper
• Genetics of Mendelian Forms of Parkinson’s Disease

  2015cites this paper
• Identification of parkin interactions: implications for Parkinson’s disease

  2015cites this paper
• Genetic variability of the retromer cargo recognition complex in parkinsonism

  2015cites this paper
• Erratum to: The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review

  2015cites this paper
• Parkinson’s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes

  2015cites this paper
• Retromer and sorting nexins in endosomal sorting.

  2015cites this paper
• Genetics and Molecular Biology of Parkinson Disease

  2015cites this paper
• Short report Open Access

  2015cites this paper
• VPS35 Parkinson’s disease phenotype resembles the sporadic disease

  2014cites this paper
• In vivo evidence of pathogenicity of VPS35 mutations in the Drosophila

  2014cites this paper
• The genetics of Parkinson’s disease: review of current and emerging candidates

  2014cites this paper
• Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson’s disease mutant of Leucine-rich repeat kinase 2 (LRRK2)

  2014cites this paper
• Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration

  2014cites this paper
• Recent advances in Parkinson’s disease genetics

  2014cites this paper
• The Vps35 D620N Mutation Linked to Parkinson's Disease Disrupts the Cargo Sorting Function of Retromer

  2014cites this paper
• Functional characterization of HtrA2 in the pathogenesis of Parkinson´s disease

  2014cites this paper
• Genotype-Phenotype Correlations in Parkinson Disease

  2014cites this paper